Royalty Report: Medical, Device, Diagnostic – Collection: 2313

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 10

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 10

Primary Industries

  • Medical
  • Device
  • Diagnostic
  • Scientific & Technical Instruments
  • Radiation
  • Therapeutic
  • X-ray
  • Cancer
  • Unspecified
  • Defense/Military
  • Supply
  • Ophthalmological
  • Security

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 2313

License Grant
The first agreement gives licensee exclusive rights  from the government organization to manufacture and distribute a Nonradioactive isotope version of NASA’s low intensity X-ray and gamma ray imaging device (patent no. 4,142,101).  

This technology provides the ability to amplify X-rays that have been converted to visible light.  The FluoroScan System is a low intensity, real time X-ray imaging device which provides high resolution images at radiation levels and at a cost well below those of conventional X-ray and fluoroscopic equipment.  The FluoroScan System technology is based on a micro channel plate image intensifier commonly known as a night vision intensifier.

IPSCIO Record ID: 2309

License Grant
The second agreement gives Company exclusive rights from the government organization to manufacture and distribute NASA’s high voltage isolation transformer (patent no. 4,510,476) and high voltage power supply (patent no. 4,517,472).  This technology allows the Company products (incl. FluoroScan System) to produce low levels of radiation.
License Property
The FluoroScan System is a low intensity, real time X-ray imaging device which provides high resolution images at radiation levels and at a cost well below those of conventional X-ray and fluoroscopic equipment.   The FluoroScan System technology is based on a micro channel plate image intensifier commonly known as a night vision intensifier.

This invention relates to electrical power supplies and, more particularly, to a power supply for providing a plurality of high voltage output signals.  High voltage power supplies have typically been low frequency networks characterized principally by their mass, bulk and relative inefficiency.  Recent advances in such fields as diagnostic x-ray devices (e.g., the Low Intensity X-ray and Gamma-ray Imaging Device disclosed in U.S. Pat. No. 4,142,101) have established a demand for portable, battery driven power supplies able to deliver a plurality of regulated, static output voltages on the order of tens of kilowatts for periods of several hours. The operational characteristics of such devices usually require that each potential furnished by a power supply be separately adjustable.

Field of Use
The rights granted apply in such fields as diagnostic x-ray devices.

IPSCIO Record ID: 5266

License Grant
The Company agrees to sell, assign, transfer, set over and convey all rights, title and interest in and to said Original Agreement, including the exclusive licenses under U.S. Patent Nos. 4,284,895 and 4,437,006 in the Medical Field.  Patent Nos. 4,284,895 issued on August 18, 1981 relates to Method and apparatus for tomographic examination of an object by penetrating radiation and Patent Nos. 4,437,006 issued on March 13, 1984 relates to Method and apparatus for measuring radiation in computer-assisted tomography and radiographic applications.
License Property
Technology relates to the construction of an x-ray tomographic scanning prototype.

The Company has an exclusive license for the worldwide rights in the medical field to two patents for its proposed medical imaging camera. The two patents relate to high-speed single photon counting cameras and camera configurations which minimize the “noise” associated with the scattering of low energy photons.

IPSCIO Record ID: 26371

License Grant
The Company entered into an Exclusive License Agreement and a Sponsored Research Agreement in connection with the development of its second-generation OsteoSystem; worldwide rights, in the field of bone densitometry; patents claiming an invention in the field of quantitative radiographic imaging.
License Property
U.S. Patents No. 5,465,284 and 5,150,394 entitled System for Quantitative Radiographic Imaging
Field of Use
Field shall mean the area of bone densitometry.

IPSCIO Record ID: 204314

License Grant
Licensor grants a worldwide, exclusive license to use and sell X-Ray Systems in the Field.  Licensee desires to be the exclusive marketing and distribution entity for X-Ray Systems.
License Property
The Parties will co-develop and co-manufacture a disposable miniature x-ray source, based on the X-SEED and associated technology, for the delivery of intravascular radiation therapy to prevent restenosis (re-narrowing) of coronary arteries following angioplasty and stent procedures.  The new system will include an integrated disposable x-ray tube and catheter and a delivery and control device to deliver intravascular radiation therapy. Both companies will manufacture components for the system, which will be co-labeled.

Pursuant to this agreement, each party will have the licensed rights to use the X-Ray System or components.  The parties have agreed to develop certain X-Ray Systems which incorporate and combine Catheter Body Subassemblies and Delivery Devices developed and manufactured by Licensee with X-Ray Tubes and Control Devices developed and manufactured by Licensor.

X-Seed is a prototype of a new system for delivering x-rays from inside blood vessels following an operation for clogged arteries.

Based on a concept of the Licensor's patented and patent-pending technology, the x-ray source uses a combination of lasers, fiber optics and high voltages to produce x-rays. The X-Seed miniature x-ray system is completely self-contained, and its key components are less than one millimeter in diameter. X-Seed is designed to be placed at the end of a fine, flexible catheter, which will then be inserted inside blood vessels to deliver a dose of radiation to the interior surface.

The overall components of the system are  Catheter Body Subassembly,  X-Ray Tube, Control Device and Delivery Device.

Field of Use
The Field shall mean the field of Intravascular Radiotherapy.

Intravascular Radiotherapy is a radiation therapy system that helps prevent the repeated narrowing of coronary arteries that have already undergone the procedure of stenting.

IPSCIO Record ID: 215206

License Grant
Licensor grants a worldwide right and license to manufacture and sell X-Ray Systems exclusively to Licensor for use in the Field.

Licensor grants a worldwide, non-exclusive license to manufacture, use and sell Delivery Devices outside the Field.

Pursuant to this agreement, each party will have the licensed rights to use the X-Ray System or components.  The parties have agreed to develop certain X-Ray Systems which incorporate and combine Catheter Body Subassemblies and Delivery Devices developed and manufactured by Licensee with X-Ray Tubes and Control Devices developed and manufactured by Licensor.

License Property
The Parties will co-develop and co-manufacture a disposable miniature x-ray source, based on the X-SEED and associated technology, for the delivery of intravascular radiation therapy to prevent restenosis (re-narrowing) of coronary arteries following angioplasty and stent procedures.  The new system will include an integrated disposable x-ray tube and catheter and a delivery and control device to deliver intravascular radiation therapy. Both companies will manufacture components for the system, which will be co-labeled.

Pursuant to this agreement, each party will have the licensed rights to use the X-Ray System or components.  The parties have agreed to develop certain X-Ray Systems which incorporate and combine Catheter Body Subassemblies and Delivery Devices developed and manufactured by Licensee with X-Ray Tubes and Control Devices developed and manufactured by Licensor.

X-Seed is a prototype of a new system for delivering x-rays from inside blood vessels following an operation for clogged arteries.

Based on a concept of the Licensor's patented and patent-pending technology, the x-ray source uses a combination of lasers, fiber optics and high voltages to produce x-rays. The X-Seed miniature x-ray system is completely self-contained, and its key components are less than one millimeter in diameter. X-Seed is designed to be placed at the end of a fine, flexible catheter, which will then be inserted inside blood vessels to deliver a dose of radiation to the interior surface.

The overall components of the system are  Catheter Body Subassembly,  X-Ray Tube, Control Device and Delivery Device.

Field of Use
The Field shall mean the field of Intravascular Radiotherapy.

Intravascular Radiotherapy is a radiation therapy system that helps prevent the repeated narrowing of coronary arteries that have already undergone the procedure of stenting.

Licensee is leveraging its core expertise in miniature x-ray technology into distinct markets including cancer treatment, intravascular care, industrial x-ray, and radiation dosimetry products.

IPSCIO Record ID: 27532

License Grant
The parties desire to amend the Agreement in order to modify their arrangements with respect to the development of the X-Ray Systems.
License Property
X-Ray Systems is based on Photoelectron's patented technology. The new system will include an integrated disposable x-ray tube and catheter and a delivery and control device to deliver intravascular radiation therapy.

Licensor is leveraging its core expertise in miniature x-ray technology into distinct markets including cancer treatment, intravascular care, industrial x-ray, and radiation dosimetry products.

The Parties will co-develop and co-manufacture a disposable miniature x-ray source, based on the X-SEED and associated technology, for the delivery of intravascular radiation therapy to prevent restenosis (re-narrowing) of coronary arteries following angioplasty and stent procedures.  The new system will include an integrated disposable x-ray tube and catheter and a delivery and control device to deliver intravascular radiation therapy. Both companies will manufacture components for the system, which will be co-labeled.

Pursuant to this agreement, each party will have the licensed rights to use the X-Ray System or components.  The parties have agreed to develop certain X-Ray Systems which incorporate and combine Catheter Body Subassemblies and Delivery Devices developed and manufactured by Licensee with X-Ray Tubes and Control Devices developed and manufactured by Licensor.

X-Seed is a prototype of a new system for delivering x-rays from inside blood vessels following an operation for clogged arteries.

Based on a concept of the Licensor's patented and patent-pending technology, the x-ray source uses a combination of lasers, fiber optics and high voltages to produce x-rays. The X-Seed miniature x-ray system is completely self-contained, and its key components are less than one millimeter in diameter. X-Seed is designed to be placed at the end of a fine, flexible catheter, which will then be inserted inside blood vessels to deliver a dose of radiation to the interior surface.

Field of Use
The Field shall mean the field of Intravascular Radiotherapy.

Intravascular Radiotherapy is a radiation therapy system that helps prevent the repeated narrowing of coronary arteries that have already undergone the procedure of stenting.

IPSCIO Record ID: 6276

License Grant
The Licensor grants to the Licensee, the exclusive right and License to make, use and sell the Product, including the Eagle Eye® night vision goggle, otherwise known as STS LP/NVG Models 2722 and 2733 (government designation, AN/PVS-21) and variants thereof that incorporate technology covered by at least one valid and unexpired claim of the Licensed Patents.
License Property
Licensed Patents shall mean United States Patent No. 5,079,416 entitled, Compact See-Through Night Vision Goggles, issued January 7, 1992 to D. Filipovich; and United States Patent No. 4,653,879 entitled, Compact See-Through Night Vision Goggles, issued March 31, 1987 to D. Filipovich as embodied in STS LP/NVG Model 2722 as defined hereto.
Field of Use
A limited non-exclusive grant of the right to use the Licensed Patents solely for the purpose of manufacturing, use and sale of the Product.

IPSCIO Record ID: 5486

License Grant
The Company has the exclusive worldwide rights to develop, manufacture and market a patented color magnetic resonance imaging technology.
License Property
Technology' shall mean a method for colorizing and displaying MRIs (MRI colorization technology – US Patents #5,332,968 and #5,410,2)

IPSCIO Record ID: 5231

License Grant
Licensor hereby grants to Licensee a non-exclusive, personal, non- transferable right and license in the Licensed Patent to make, have made, use and sell or otherwise dispose of Licensed Products.
License Property
Licensor is the parent company of the owner of the entire right, title and interest in United States Patent 4,366,382 entitled 'X-ray Line Scan System for use in Baggage Inspection' (the Licensed Patent) and has the right to make this license.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.